2 - 60 day FRN

Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices
requirements of section 3.108(c)(2)(i) of
the Patient Safety Rule regarding
notification of providers that have
reported to the PSO. In addition,
according to section 3.108(c)(2)(ii) of the
Patient Safety Rule regarding
disposition of PSWP, the PSO has 90
days from the effective date of delisting
and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at http://www.pso.AHRQ.gov/
index.html.
Dated: November 14, 2013.
Richard Kronick,
Director.
[FR Doc. 2013–28284 Filed 11–25–13; 8:45 am]
BILLING CODE 4160–90–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations: Delisting
for Cause for Leadership Triad
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
AGENCY:

AHRQ has delisted
Leadership Triad due to its failure to
correct a deficiency. The Patient Safety
and Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109–41,
42 U.S.C. 299b–21—b–26, authorizes
the listing of Patient Safety
Organizations (PSOs), which are entities
or component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
and Quality Improvement Final Rule
(Patient Safety Rule) to implement the
Patient Safety Act. AHRQ administers
the provisions of the Patient Safety Act
and Patient Safety Rule relating to the
listing and operation of PSOs.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on October 4, 2013.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: http://
www.pso.AHRQ.gov/index.html.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;

emcdonald on DSK67QTVN1PROD with NOTICES

SUMMARY:

VerDate Mar<15>2010

18:04 Nov 25, 2013

Jkt 232001

Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email: pso@
AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, provides for
the formation of PSOs, which collect,
aggregate, and analyze confidential
information regarding the quality and
safety of health care delivery. The
Patient Safety Rule, 42 CFR Part 3,
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule.
Section 3.108(d) of the Patient Safety
Rule requires AHRQ to provide public
notice when it removes an organization
from the list of federally approved
PSOs.
In response to a Notice of Proposed
Revocation and Delisting sent by AHRQ
pursuant to 42 CFR 3.108(a)(3)(iii)(C),
Leadership Triad stated that it did not
meet the requirement that, within 24
months of initial listing, the PSO must
have two bona fide contracts with
different providers for the purpose of
receiving and reviewing patient safety
work product. Accordingly, pursuant to
42 CFR 3.108(a)(5), the notice of
proposed revocation was affirmed and
AHRQ revoked the listing of Leadership
Triad, PSO number P0117, a component
entity of Triad Health Care LLC,
effective at 12:00 Midnight ET (2400) on
October 4, 2013.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at http://www.pso.AHRQ.gov/
index.html.
Dated: November 14, 2013.
Richard Kronick,
Director.
[FR Doc. 2013–28279 Filed 11–25–13; 8:45 am]
BILLING CODE 4160–90–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0770]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

70561

opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to LeRoy Richardson,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to omb@
cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Proposed Project
National HIV Behavioral Surveillance
System (NHBS)—(0920–0770,
Expiration 05/31/2014)—Extension—
Center for HIV, Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The purpose of this data collection is
to monitor behaviors of persons at high
risk for infection that are related to
Human Immunodeficiency Virus (HIV)
transmission and prevention in the
United States. The primary objectives of
the NHBS system are to obtain data from
samples of persons at risk to: (a)
Describe the prevalence and trends in
risk behaviors; (b) describe the
prevalence of and trends in HIV testing
and HIV infection; (c) describe the
prevalence of and trends in use of HIV
prevention services; (d) identify met and
unmet needs for HIV prevention
services in order to inform health
departments, community based
organizations, community planning
groups and other stakeholders.
By describing and monitoring the HIV
risk behaviors, HIV seroprevalence and
incidence, and HIV prevention
experiences of persons at highest risk
for HIV infection, NHBS provides an
important data source for evaluating
progress towards national public health

E:\FR\FM\26NON1.SGM

26NON1

70562

Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices

goals, such as reducing new infections,
increasing the use of condoms, and
targeting high risk groups.
The Centers for Disease Control and
Prevention request approval for a 3-year
extension of this information collection.
Data are collected through anonymous,
in-person interviews conducted with
persons systematically selected from 25
Metropolitan Statistical Areas (MSAs)
throughout the United States; these 25
MSAs were chosen based on having
high AIDS prevalence. Persons at risk
for HIV infection to be interviewed for
NHBS include men who have sex with
men (MSM), injecting drug users (IDU),
and heterosexuals at increased risk of
HIV (HET). A brief screening interview
will be used to determine eligibility for

CDC estimates that NHBS will
involve, per year in each of the 25
MSAs, eligibility screening for 50 to 200
persons and eligibility screening plus
the behavioral assessment with 500
eligible respondents, resulting in a total
of 37,500 eligible survey respondents
and 7,500 ineligible screened persons
during a 3-year period. Data collection
will rotate such that interviews will be
conducted among one group per year:
MSM in year 1, IDU in year 2, and HET
in year 3. The type of data collected for
each group will vary slightly due to
different sampling methods and risk
characteristics of the group.
Participation of respondents is
voluntary and there is no cost to the
respondents other than their time.

participation in the behavioral
assessment.
The data from the behavioral
assessment will provide estimates of (1)
Behavior related to the risk of HIV and
other sexually transmitted diseases, (2)
prior testing for HIV, (3) and use of HIV
prevention services.
All persons interviewed will also be
offered an HIV test, and will participate
in a pre-test counseling session. No
other federal agency systematically
collects this type of information from
persons at risk for HIV infection. These
data have substantial impact on
prevention program development and
monitoring at the local, state, and
national levels.

ESTIMATE OF ANNUALIZED BURDEN HOURS
Total burden
(in hours)

Form

Persons Screened ............................
Eligible Participants: ..........................
Eligible Participants: ..........................
Eligible Participant ............................
Peer Recruiters: ................................

Eligibility Screener ............................
Behavioral Assessment MSM ..........
Behavioral Assessment IDU ............
Behavioral Assessment HET ...........
Recruiter Debriefing .........................

15,000
4,167
4,167
4,167
4,167

1
1
1
1
1

5/60
30/60
54/60
39/60
2/60

1,250
2,084
3,750
2,709
139

Total Annualized Burden ...........

...........................................................

........................

........................

........................

9,932

LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–28281 Filed 11–25–13; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14CW]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

emcdonald on DSK67QTVN1PROD with NOTICES

Average
burden per
response
(hours)

Number of
responses per
respondent

Number of
respondents

Respondent

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600

VerDate Mar<15>2010

18:04 Nov 25, 2013

Jkt 232001

Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to [email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Health and Socioeconomic Sequelae
of the WTC Disaster among
Responders—New—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Since the inception of the World
Trade Center (WTC) Medical Monitoring
and Treatment Program (MMTP), health
reports have focused on disorders of the

PO 00000

Frm 00035

Fmt 4703

Sfmt 4703

aerodigestive tract and mental health
consequences, and with the exception of
spirometry, comparisons with general
and normative population data have not
been made. Furthermore, none of the
previous studies comprehensively
evaluated the changes of socioeconomic
status in WTC responders after 9/11.
Lowered socioeconomic status (SES) is
an important potential consequence of
WTC exposures that can negatively
impact the physical and mental health
status among WTC responders. The
main objective of this study is to
establish an expanded occupational
health surveillance system that
summarizes overall health status of
WTC responders over time, and also
provides information about symptoms
not previously reported. Through this
work, it is possible that other health
outcomes will be identified and
reported, such as autoimmune
disorders. This expanded surveillance
system will supplement reports the
WTC Data Center (DC) will be
providing. To provide a reference
population, the WTC cohort will be
compared to the National Center for
Health Statistics (NCHS) and the
Behavioral Risk Factor Surveillance
System (BRFSS) to compare physical
and mental health status by matching
variables. The comparison will estimate

E:\FR\FM\26NON1.SGM

26NON1